|
|
Post by suebeeee1 on Dec 19, 2015 6:02:13 GMT -5
|
|
|
|
Post by mindovermatter on Dec 19, 2015 8:26:32 GMT -5
Thank you for posting it but how is his article any different than what many users post on here voicing their own opinions? My point is there is nothing new he offers that hasn't been discussed here time and time again, imo. And thank god for the Shkreli news. It's been a very effective diversion from the dumpster fire Mannkind has been this holiday season. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 19, 2015 20:42:11 GMT -5
Thank you for posting it but how is his article any different than what many users post on here voicing their own opinions? My point is there is nothing new he offers that hasn't been discussed here time and time again, imo. And thank god for the Shkreli news. It's been a very effective diversion from the dumpster fire Mannkind has been this holiday season. Mindovermatter your username clearly does not match your personality. CNA finance articles were pretty poor but he has gotten better as he has learned about Afrezza. |
|
|
|
Post by dreamboatcruise on Dec 20, 2015 16:33:25 GMT -5
Thank you for posting it but how is his article any different than what many users post on here voicing their own opinions? My point is there is nothing new he offers that hasn't been discussed here time and time again, imo. And thank god for the Shkreli news. It's been a very effective diversion from the dumpster fire Mannkind has been this holiday season. Mindovermatter your username clearly does not match your personality. CNA finance articles were pretty poor but he has gotten better as he has learned about Afrezza. His articles often seem rather amateurish. Such as in this one claiming MNKD is working on regulatory approval in Europe, as if it isn't spelled out very clearly in the agreement with SNY that SNY is responsible for this. In the past he had talked about "improving" formulary placement when none was occurring. Also, if I agreed with him that MNKD should break ties with SNY and that investors need to barrage SNY with phone calls, I would come to exactly the opposite conclusion to him. If what is going on behind the scenes with SNY is truly so bad as to warrant starting from scratch trying to find a new partner, then the chance of 2016 being in any way good for MNKD investors would be very slim to none. |
|
|
|
Post by trenddiver on Dec 20, 2015 16:44:18 GMT -5
Just so board members are aware, CNA Finance is not in any affiliated with the CNA Financial, the multi billion dollar insurance entity. You have to wonder about any company that tries to confuse readers/investors by utilizing a name closely resembling that of a major company. I surprised CNA Financial has not sent this company a cease and desist order. Trend |
|
|
|
Post by mindovermatter on Dec 20, 2015 17:13:09 GMT -5
Just so board members are aware, CNA Finance is not in any affiliated with the CNA Financial, the multi billion dollar insurance entity. You have to wonder about any company that tries to confuse readers/investors by utilizing a name closely resembling that of a major company. I surprised CNA Financial has not sent this company a cease and desist order. Trend Bingo. As I originally posted, the guy has no more credibility than anyone on here does. His writings are meaningless in the grand scheme of things because no one, other than shorts, have gotten the MNKD story right to date in regards to how it is trading. I hope to be proven wrong with buyout news that comes out tomorrow prior to the market opening. My wife is smarting over my decision to invest in it and she is threatening to start an affair with the pool boy if I don't show positive results soon. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 21, 2015 0:22:20 GMT -5
Mindovermatter your username clearly does not match your personality. CNA finance articles were pretty poor but he has gotten better as he has learned about Afrezza. His articles often seem rather amateurish. Such as in this one claiming MNKD is working on regulatory approval in Europe, as if it isn't spelled out very clearly in the agreement with SNY that SNY is responsible for this. In the past he had talked about "improving" formulary placement when none was occurring. Also, if I agreed with him that MNKD should break ties with SNY and that investors need to barrage SNY with phone calls, I would come to exactly the opposite conclusion to him. If what is going on behind the scenes with SNY is truly so bad as to warrant starting from scratch trying to find a new partner, then the chance of 2016 being in any way good for MNKD investors would be very slim to none. I'm trying to be nice because I made some harsh comments in past about his work on other platform and people were offended. I believe he is purely looking for clicks and taking a positive approach when everything else is negative is not a terrible strategy. |
|
|
|
Post by mnholdem on Dec 21, 2015 10:57:23 GMT -5
There is a Joshua Rodriguez on Sanofi's Afrezza USA team.
Is he the same person as the Joshua Rodriguez who publishes the CNA Finance articles? I would think so. Perhaps it's just an odd coincide.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 21, 2015 13:35:05 GMT -5
There is a Joshua Rodriguez on Sanofi's Afrezza USA team. Is he the same person as the Joshua Rodriguez who publishes the CNA Finance articles? I would think so. Perhaps it's just an odd coincide. Not even close to being the same person |
|
